Announcement on Completing Share Transfer of Invested Company
Filed with SSE · · 2 pages · Chinese
Zhejiang Huakang Pharmaceutical Co., Ltd. on 6ix
Earlier from Zhejiang Huakang Pharmaceutical
- Announcement on Convening the 2025 Semi-annual Performance Briefing
- Announcement on Implementation of Semi-annual Dividend Distribution for 2025
- Indicative Announcement on Stopping Conversion of "Huakang Convertible Bonds" when Implementing 2025 Interim Dividend Distribution
- Announcement on Resignation of Non-independent Director and Election of Employee Representative Director
- Announcement on Returning Idle Raised Funds Temporarily Used for Supplementing Current Capital in Advance
Later from Zhejiang Huakang Pharmaceutical
- Announcement on the Closure of the Special Account for Proceeds from the Initial Public Offering
- Announcement on Conducting Commodity Futures, Options, and Foreign Exchange Hedging Business
- Announcement on Convening the Q3 2025 Performance Briefing
- Announcement on Holding the Investor Briefing on Terminating Major Asset Restructuring
- Announcement on Interest Payment for "Huakang Convertible Bonds" in 2025
Follow Zhejiang Huakang Pharmaceutical into a list and get an email when it puts out news.
Follow Zhejiang Huakang Pharmaceutical